Author： Espirito Santo Ana Medeiros Rui
Publisher： Informa Healthcare
ISSN： 1742-5255
Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.12, 2013-12, pp. : 1625-1634
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Non-Hodgkin's Lymphoma in the Elderly
By Caimi Paolo F. Barr Paul M. Berger Nathan A. Lazarus Hillard M.
Drugs & Aging, Vol. 27, Iss. 3, 2010-03 ,pp. :
Access to resources
Recommend
By Rule Simon
Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. :
Chemokines and antagonists in non-Hodgkin's lymphoma
By Golay Josée Introna Martino
Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. :
QOL in non-Hodgkin's and Hodgkins lymphoma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 338, 2001-01 ,pp. :
Antiangiogenic Therapies in Non-Hodgkin's Lymphoma
Current Cancer Drug Targets, Vol. 11, Iss. 9, 2011-11 ,pp. :